Biological and Clinical Changes in a Pediatric Series Treated with Off-Label JAK Inhibitors
Open Access
- 20 October 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (20) , 7767
Abstract
Off-label use of medications is still a common practice in pediatric rheumatology. JAK inhibitors are authorized in adults in the treatment of rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Although their use is not authorized yet in children, JAK inhibitors, based on their mechanism of action and on clinical experiences in small series, have been suggested to be useful in the treatment of pediatric interferon-mediated inflammation. Accordingly, an increased interferon score may help to identify those patients who might benefit of JAK inhibitors. We describe the clinical experience with JAK inhibitors in seven children affected with severe inflammatory conditions and we discuss the correlation between clinical features and transcriptomic data. Clinical improvements were recorded in all cases. A reduction of interferon signaling was recorded in three out of seven subjects at last follow-up, irrespectively from clinical improvements. Other signal pathways with significant differences between patients and controls included upregulation of DNA repair pathway and downregulation of extracellular collagen homeostasis. Two patients developed drug-related adverse events, which were considered serious in one case. In conclusion, JAK inhibitors may offer a valuable option for children with severe interferon-mediated inflammatory disorders reducing the interferon score as well as influencing other signal pathways that deserve future studies.Keywords
Funding Information
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, Trieste (Italy) (RC #24/2017)
This publication has 38 references indexed in Scilit:
- Janus Kinase Inhibition in the Aicardi–Goutières SyndromeNew England Journal of Medicine, 2020
- Machine learning in rheumatology approaches the clinicNature Reviews Rheumatology, 2020
- Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literaturePulmonary Circulation, 2019
- Development of a Validated Interferon Score Using NanoString TechnologyJournal of Interferon & Cytokine Research, 2018
- The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessibleNucleic Acids Research, 2016
- A preliminary disease severity score for juvenile systemic sclerosisArthritis & Rheumatism, 2012
- Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus: Association with Distinct Clinical PhenotypesBioMed Research International, 2011
- Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus ErythematosusHuman Genomics and Proteomics, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Research, 2008